Etomidate Market Segmentation by Product Type (Induction Agent, and Fat Emulsion); and by End-User (Hospitals, Clinics, Ambulatory Surgical Centers, and Others) – Global Demand Analysis & Opportunity Outlook 2030

Buy Now Report ID: 3813 | Published Date: Feb 06, 2023

Global Etomidate Market Regional Synopsis

On the basis of geographical analysis, the global etomidate market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and the Middle East & Africa region. The market in Asia Pacific is estimated to witness noteworthy growth over the forecast period largely on the back of the favorable government policies regarding the use of etomidate in medical procedures in the region. In addition, rapidly growing healthcare infrastructure is also expected to drive the market growth in the region in the coming years. Moreover, the market in North America is projected to gather the largest share during the forecast period ascribing to the increasing prevalence of cardiovascular diseases, and increasing number of surgical procedures in the region. According to the Agency for Healthcare Research and Quality, there were a total of 9,605,000 inpatient stays for any operation room procedure in the United States in 2018, out of these 8,425,900 stays were for principal or procedures. 

Etomidate Market Share

Get more information on this reportDownload Sample PDF

The global etomidate market is further classified on the basis of region as follows:

  • North America (U.S. & Canada) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market size, Y-O-Y growth & Market Players Analysis & Opportunity Outlook
  • Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC (Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), Poland, Turkey, Russia, Rest of Europe) Market size, Y-O-Y growth Market Players Analysis & Opportunity Outlook
  • Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market size, Y-O-Y growth & Market Players Analysis & Opportunity Outlook
  • Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market size, Y-O-Y growth Market Players Analysis & Opportunity Outlook

Etomidate Market
Get more information on this report: Request Free Sample PDF

Major Macro-Economic Indicators Impacting the Market Growth

Etomidate Market

According to the statistics by the World Health Organization, the global per capita healthcare expenditure amounted to USD 1,064.741 in the year 2017. The worldwide healthcare expenditure per person grew from USD 864.313 in 2008 to USD 1,110.841 in 2018, where the U.S. is the top country that amounted to healthcare expenditure of USD 10, 623.85 per capita in 2018. As of 2018, the domestic general government healthcare spending in the U.S. was USD 5355.79, which grew from USD 3515.82 in 2008. These are some of the factors responsible for market growth over the past few years. Moreover, as per the projections by the Centers for Medicare & Medicaid Services (CMS), the estimated average annual percent change related to National Health Expenditures (NHE) in the U.S. was 5.2% in 2020 as compared to 2019 (4.5%). Furthermore, the National Health Expenditures are projected to reach USD 6,192.5 Billion in 2028, where the per capita expenditure is estimated to touch USD 17,611 in the same year. These are notable indicators that are anticipated to create lucrative business opportunities in upcoming years.

Market Segmentation


Our in-depth analysis of the global etomidate market includes the following segments:

By Product Type

  • Induction Agent
  • Fat Emulsion

By End-User

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Others

Growth Drivers

  • Increasing Demand for Effective Anesthetic Drugs
  • Growing Research and Development Activities for the Development of Drugs for Cardiovascular Diseases


  • Side-Effects Related to the Use of Etomidate
  • Strict Government Regulations for the Administration of the Drug

Etomidate Market
Get more information on this report: Request Free Sample PDF

Top Featured Companies Dominating the Market

    • Caplin Steriles Limited
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis 
    • AuroMedics Pharma LLC
    • Avet Pharmaceuticals Inc
    • Merck KGaA
    • Shanghai Fosun Pharmaceutical Co., Ltd.
    • Cadila Healthcare Limited
    • Mylan N.V.
    • Hikma Pharmaceuticals plc
    • B. Braun Melsungen AG


In The News

  • December 2020- Caplin Steriles Limited, subsidiary company of Caplin Point Laboratories Limited was granted approval from the U.S. Food and Drug Administration for its etomidate injection USP, 20mg/10mL (2mg/mL) and 40 mg/20ml (2mg/mL) single-dose vial presentations.

  • September 2018- Avet Pharmaceuticals Inc. announced the immediate availability of Etomidate Injection, USP, in 20mg/10mL and 40mg/20mL strengths to the company’s growing portfolio of generic injectable products.


Global Economic Impact

Request Insights
Despite Inflation & Fearing Recession, Businesses Across the Globe Expected to Do Better in 2023:

In 2023, market players might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain.
Controlling Inflation has become the first priority for global economies from last quarter of 2022 and to be followed in 2023. With skewed economic situations, rise in interest rate by governments to control spending and inflation, spiked oil and gas prices, high inflation, geo-political issues including U.S. & China trade war, Russia-Ukraine conflict to intensify the global economic issues.
The interest rates in the U.S. may be less sensitive in 2023 as compared to 2022; sigh of relief for businesses. Positive business sentiments, healthy business balance sheets, growth in construction spending (private construction value in 2022 stood at $1,429.2 billion, 11.7 percent (±1.0 percent) above the $1,279.5 billion spent in 2021, Residential construction in 2022 was $899.1 billion, up by 13.3 percent (±2.1 percent) from $793.7 billion in 2021, non-residential construction touched $530.1 billion, 9.1 percent (±1.0 percent) above the $485.8 billion in 2021.) showcases minimal impact of recession in the country.
Similarly, spiked spending in the European and major Asia economics including, India, China & Japan to showcase less impact on the global demand.

Author Credits:  Radhika Gupta, Shivam Bhutani

Key Questions Answered in the Report

1) What are the major factors driving the growth of the etomidate market?

Ans: The major factors driving market growth are increasing demand for effective anesthetic drugs, and growing research and development activities for the development of drugs for cardiovascular diseases.

2) What would be the CAGR of etomidate market over the forecast period?

Ans: The market is anticipated to attain a moderate CAGR over the forecast period, i.e., 2022 – 2030.

4) Which region will provide more business opportunities for growth of etomidate market in future?

Ans: Asia Pacific will provide more business opportunities for market growth owing to the favorable government policies regarding the use of etomidate in medical procedures in the region.

5) Who are the major players dominating the etomidate market?

Ans: The major players in the market are Caplin Steriles Limited, AuroMedics Pharma LLC, Avet Pharmaceuticals Inc, Merck KGaA, and others.

6) How are the company profiles selected?

Ans: The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.

7) What are the segments in the etomidate market?

Ans: The market is segmented by product type, end-user, and by region.

8) Which segment captures the largest market size in the product type segment in the etomidate market?

Ans: The fat emulsion segment is anticipated to hold largest market size and is estimated to grow at a notable CAGR over the forecast period and display significant growth opportunities.

8) What are the challenges affecting the market growth?

Ans: Side-effects related to the use of etomidate, and strict government regulations for drug administration are estimated to hamper the market growth.

Let Us Hear About Your Requirements:

Submit Your Request For Proposal (RFP)

 Request Free Sample Copy